When communities collaborate, that’s when patients win. Bringing together experts at the Chronic Myeloid Leukemia (#CML) Patient Advocate and Medical Expert Leadership Summit at #ASCO2024 sparked a journey to #reimaginemedicine together for patients living with this #bloodcancer. Thank you to our participants for joining us and embracing this time together to address gaps and support CML patients.
Novartis US
Pharmaceutical Manufacturing
East Hanover, New Jersey 95,518 followers
Transforming people’s lives by reimagining medicine.
About us
At Novartis US, our mission is to reimagine medicine and discover new ways to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis products reach nearly 800 million people globally and we are finding innovative ways to provide solutions to address the evolving needs of patients. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Over 41% of global Novartis R&D expenditure ($3.9 billion) was invested in the US in 2019. Our US presence is comprised of nearly 15,000 employees, with campuses across the country including in East Hanover, NJ, Cambridge, MA, and Indianapolis, IN. See our community guidelines: http://bit.ly/2JnT2CP
- Website
-
https://www.novartis.us/
External link for Novartis US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- East Hanover, New Jersey
- Founded
- 1996
- Specialties
- Research, Innovation, Quality, Sustainability, Innovative Medicines, Generic Medicines and Biosimilars, Unique Portfolio Focuses & Broad Healthcare Portfolio, Cell & Gene Therapy, and Data & Digital
Updates
-
Recently our Cancer Hope Employee Resource Group (ERG) and Oncology teams came together at East Hanover for a Health Fair. This gathering was dedicated to raising awareness and providing valuable information and screening resources for our employees impacted by cancer. Our Cancer Hope ERG is committed to empowering individuals affected by cancer and fostering a strong community of support within Novartis. During this event, we focused on reinforcing our dedication to those living with prostate and blood cancers, paroxysmal nocturnal hemoglobinuria and other rare disorders. We are proud to stand beside our employees in making a meaningful impact in the lives of those facing these challenging diseases. Thank you to everyone who participated, and let's continue working together to drive positive change for patients. #ERG
-
-
As summer comes to a close, we wanted to take a moment to reflect on the experiences our interns had with us at Novartis US. Watch this short video to hear directly from our interns about their favorite parts of their time with us and what they learned along the way. #ReimaginingMedicine
-
Our vision is a world where equitable healthcare is achievable for everyone. For Black men living with prostate cancer, the current landscape falls short. Rodney Gillespie, US head of Oncology at Novartis, recently joined the Congressional Black Caucus Foundation’s 53rd Annual Legislative Conference #ALC53 to discuss the very real disparities that Black men with prostate cancer experience. Together with representatives from Congress and the patient advocacy community, Rodney shared the importance of partnership and channeling innovation at Novartis to address these inequities. As we recognize the conclusion of #ProstateCancerAwarenessMonth, we are proud to stand with the community, and will continue #reimaginingmedicine for all those affected by prostate cancer.
-
-
In the United States, ~400,000 people struggle with chronic spontaneous urticaria (CSU), despite taking antihistamines. This condition, which is characterized by itchy hives or deep tissue swelling may impact daily life, including how they feel about themselves and their relationships with others. This #WorldUrticariaDay, we are honored to launch Spontaneous Connections, a new video series highlighting the individual and shared experiences of people in the #CSU community. Check out Chapter 1 now at https://lnkd.in/gr4g_TBJ
Watch Chronic Hives Stories
-
This #BloodCancerAwarenessMonth, we’re showcasing our commitment to supporting people living with chronic myeloid leukemia (CML), a disease that affects thousands every year. At Novartis, we continue #ReimaginingMedicine for people living with CML through partnership with the community.
The LLS #LightTheNight season is so close – we can feel it! ✨ Help us bring light to the darkness of cancer this fall by registering for an event near you 👉 https://bit.ly/4dHDJkd
-
-
-
-
-
+3
-
-
Did you know approximately one in six leukemia cases are chronic myeloid leukemia (CML)? We are joining the The Leukemia & Lymphoma Society at #LighttheNight walks across the country this fall to raise awareness for CML. Join us in a city near you as we honor and bring light to those affected by leukemia.
-
-
Meet Nicole. Like her, many people diagnosed with early #breastcancer face concerns around their cancer coming back, even after achieving remission. Despite adjuvant therapies available to date, many diagnosed with HR+/HER2- stage II or III early breast cancer (eBC) may experience disease recurrence. Today’s FDA approval can help us change these statistics and support patients in navigating life after diagnosis and treatment. We are grateful to people like Nicole, who together with other patients and their loved ones, health care providers, scientists and advocates, participated in the research leading to this approval, helping elevate care, improve outcomes and empower more people diagnosed with eBC. #bcsm #ReimaginingMedicine, together
-
This #PNHAwarenessWeek, we’re dedicated to raising awareness about paroxysmal nocturnal hemoglobinuria (PNH), a rare and chronic blood disorder. Understanding the challenges faced by people with PNH is an important step in helping them to better manage their disease. At Novartis, to drive meaningful change for patients, we are focused on addressing unmet needs for people living with diseases such as PNH. Learn more about the condition, and efforts to support those with PNH: https://lnkd.in/gDUuRUUk
-
Today we announced the construction of two new radioligand therapy (RLT) manufacturing facilities, one of which will produce critical isotopes necessary to create these medicines. As the leader in RLT development and delivery, we remain committed to pioneering RLT science and broadening manufacturing capabilities to support the growing demand for this novel approach to cancer care.